SCHEMBL5659320

SCHEMBL5659320

Cc1cccc(N2C(=O)C(c3cc(C)c(O)c(C)c3)(c3cc(C)ccc3O)c3ccccc32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.37
GPR55 Q9Y2T6 2/20 0.37
PKM P14618 1/20 0.37
SLC6A2 P23975 1/20 0.37
HSP90AA1 P07900 1/20 0.36
MGLL Q99685 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 6/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
XBP1 P17861 1/20 0.35
ADAMTS5 Q9UNA0 1/20 0.35
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5661875 0.92 SLC6A2 (0.37) CNR1GPR55PKMSLC6A2HSP90AA1
SCHEMBL5662233 0.91 HSP90AA1 (0.41) CNR1GPR55PKMSLC6A2HSP90AA1
SCHEMBL5661171 0.91 ADAMTS5 (0.39) CNR1GPR55PKMMGLLMAPT
SCHEMBL5659537 0.90 SLC6A2 (0.36) CNR1GPR55PKMSLC6A2HSP90AA1
SCHEMBL14457635 0.90 SLC6A2 (0.36) CNR1GPR55PKMSLC6A2HSP90AA1
SCHEMBL5663116 0.90 SLC6A2 (0.36) CNR1GPR55PKMSLC6A2HSP90AA1
SCHEMBL5660824 0.88 SLC6A2 (0.35) CNR1GPR55SLC6A2HSP90AA1MGLL
SCHEMBL5660992 0.88 OPRL1 (0.35) CNR1GPR55PKMADAMTS5
SCHEMBL5659702 0.86 NPSR1 (0.37) CNR1GPR55PKMSLC6A2HSP90AA1
SCHEMBL5658939 0.85 SLC6A2 (0.36) CNR1GPR55PKMSLC6A2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 CNR1 362/4885GPR55 77/4885PKM 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.